Fundraising Fox

EuMentis Therapeutics

Newton, US · Founded 2019 · Delaware corporation · 2 known investors

eumentistx.com ↗
Biotechin /eumentis-therapeutics-inc

Founders & leadership

AP
Andrew PearlmanDirector
RM
Randall MarshallExecutive Officer
MT
Mark TepperExecutive Officer, Director
JL
James LarrickDirector

Investors · 2

Joyance PartnersBerlin
Social StartsSan Francisco

Reported raises · per SEC filings

Form D private placements
▶$765KraisedJun 2024 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Maryann BrylaDirector
  • James LarrickDirector
  • Randall MarshallExecutive Officer
  • Kim PatrickDirector
  • Mark TepperExecutive Officer, Director
  • Andrew PearlmanDirector
Offering amount
$2M
Amount sold
$765K
Minimum investment
$20K
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedMar 2023 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • mark TepperExecutive Officer, Director
  • Kim PatrickDirector
  • Randall MarshallExecutive Officer
  • Maryann BrylaDirector
  • Andrew PearlmanDirector
  • James LarrickDirector
Offering amount
$20M
Amount sold
$4M
Minimum investment
$100K
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedApr 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Randall MarshallExecutive Officer
  • Mark TepperExecutive Officer, Director
  • Maryann BrylaDirector
  • James LarrickDirector
  • Amar KapurDirector
  • Andrew PearlmanDirector
Offering amount
$5M
Amount sold
$5M
Minimum investment
$5M
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedSep 2020 · 25 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew PearlmanDirector
  • Randall MarshallExecutive Officer
  • Mark TepperExecutive Officer, Director
  • James LarrickDirector
Offering amount
$3.3M
Amount sold
$1.5M
Minimum investment
$25K
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.